B. Braun obtains permanent injunction
Prevails in case against Terumo Corporation for its Introcan Safety IV catheter patent
German medical device manufacturer B. Braun Melsungen AG and its US subsidiary B. Braun Medical Inc. have succeeded in obtaining a permanent injunction in the patent infringement case against Japan's Terumo Corporation and its US subsidiary Terumo Medical Corporation.
On 21 April 2011, the US District Court for the District of Delaware granted an immediate and permanent order stopping Terumo from selling, or offering to sell, the Surshield Safety IV catheter in the acute care market, precluding Terumo from bidding against B. Braun on expiring GPO contracts.
Terumo will be permitted to continue selling the Surshield Safety IV catheter into the alternative care market until 1 June 2012, after which it cannot make, sell, use or offer the Surshield Safety Catheter in the US. B. Braun will seek damages and other relief for Terumo's infringement.
B. Braun's win follows a previous verdict awarded in November 2010, confirming the validity of an infringed claim of B. Braun's 2007 patent (US Patent 7,264,613) for its Introcan Safety IV Catheter.